PredictTB

Using Biomarkers to Predict TB Treatment Duration


Description

Shortening the duration of treatment for patients with drug sensitive tuberculosis from 6 to 4 months has been attempted many times in clinical trials but thus far all have failed. These failures reveal the incomplete understanding of factors driving the need for such extensive treatments. The objective of PredictTB is to identify those patients who are cured at 16 weeks, successfully accomplishing treatment shortening even with present drugs.

Coordinator
Prof Gerhard Walzl
Stellenbosch University
Phone: +27 21 938 9158
Email
Programme
Horizon 2020 & sub-programmes
Duration
60 months (February 2017 - January 2022)
Project funding
€ 7,722,491.00
Project partners
8
About Eurice

Eurice offers knowledge-based consultancy services in project and innovation management.

Eurice Head Office
Heinrich-Hertz-Allee 1
66386 St. Ingbert
Germany
Phone: +49 6894 388130
Email
Eurice Berlin
Alt-Reinickendorf 25
13407 Berlin
Germany
Phone: +49 30 374415840
Email